Fenoldopam hydrobromide
CAS: 67287-54-1
Ref. 3D-FF23259
1mg | Discontinued | ||
2mg | Discontinued | ||
5mg | Discontinued | ||
10mg | Discontinued | ||
25mg | Discontinued |
Product Information
- 6-Chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H-3-benzazepine-7,8-diol hydrobromide(±)-Fenoldopam hydrobromide(±)-SKF 82526 hyd robromide
- 1H-3-Benzazepine-7,8-diol, 6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-, hydrobromide
- 1H-3-Benzazepine-7,8-diol, 6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-, hydrobromide (1:1)
- 6-chloro-1-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol hydrobromide (1:1)
- 6-chloro-7,8-dihydroxy-1-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-1-benzazepin-3-ylium bromide
- Fenoldopam monohydrobromide
- 6-Chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(4-hydroxyphenyl)-1H-3-benzazepinium bromide
Fenoldopam is a drug that belongs to the group of drugs used as a control method. It is used in the treatment of inflammatory diseases and has been shown to be effective against epithelial cells and endothelial cells in vitro. Fenoldopam can be used to reduce the production of protein kinase C, which is responsible for cancer cell proliferation. This drug has also been shown to inhibit escherichia coli growth by binding to its ribosome, thereby inhibiting protein synthesis. Fenoldopam also inhibits cancer cell proliferation through its ability to induce apoptosis.